Skip to content

Photobiomodulation Dosimetry s in Patients With Orofacial Pain

Photobiomodulation Dosimetry Based on Anthropometric and Hemodynamic Variables in Patients With Orofacial Pain

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06065969
Enrollment
240
Registered
2023-10-04
Start date
2023-10-10
Completion date
2024-11-20
Last updated
2023-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orofacial Pain, Tension-Type Headache

Keywords

orofacial pain, Tension-Type Headache, photobiomodulation

Brief summary

This project aims to validate a dosimetry model for photobiomodulation treatment in patients with orofacial pain and tension-type headache symptoms. The study will involve 240 participants divided into four age groups. Different treatment approaches will be applied, including local photobiomodulation and systemic laser therapy. Various physiological measurements will be taken before, during, and after the treatments, including skin type, weight, height, blood pressure, and heart rate. Additionally, data from questionnaires on pain and headache symptoms will be analyzed. Monte Carlo simulation will be employed to validate the model based on these measurements and light transmission. The research addresses the need for effective pain management strategies in cases where medication-based treatments may have unwanted side effects.

Interventions

RADIATIONPhotobiomodulation

660 nm and 100 mW, directing the light beam towards the radial artery region, for 10 minutes per session.

Sponsors

University of Nove de Julho
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
7 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

Individuals of both sexes, between 7 and 65 years of age

Exclusion criteria

Participants with the following characteristics will be excluded: Pregnant individuals Individuals with arrhythmia Individuals with Thrombocytopenia Individuals with Sickle Cell Anemia Individuals with a pacemaker Individuals with alterations in coagulation factors

Design outcomes

Primary

MeasureTime frameDescription
Headache and orofacial paintwo weeksHeadache and orofacial pain assessed using the Visual Analog Scale from zero to 10.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026